Drug Search Results
More Filters [+]

CAPNOSTREAM-20

Alternative Names: capnostream-20, capnostream20, capnostream 20
Latest Update: 2022-05-10
Latest Update Note: Clinical Trial Update

Product Description

The Capnostream 20p patient monitor with Microstream technology provides a complete measurement of a patients oxygenation and ventilation status.

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Device

Route of Administration: Nasal

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Medtronic
Company Location: DUBLIN L2 2
Company CEO: Geoffrey S. Martha
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for CAPNOSTREAM-20

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT05368740

N/A

Completed

Neuromyelitis Optica|Obesity, Morbid|Anesthesia Related|Hypertension, Renal|Pulmonary Heart Disease|Heart Block|Kidney Diseases|Pain, Postoperative

2021-01-31

MDT17026

N/A

Terminated

Other

2019-12-14

2018P000152

N/A

Completed

Other

2019-03-08

D0006746A

N/A

Completed

Pulmonary Valve Insufficiency|Respiratory Insufficiency

2014-09-01

Recent News Events

Date

Type

Title